|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1986-7-28
|
|
pubmed:abstractText |
The neurological mouse mutant twitcher is characterized by a genetic deficiency of galactosylceramide beta-galactosidase (galcerase) (EC 3.2.1.46) which also represents lactosylceramide beta-galactosidase I (lactosidase I) activity. The assay conditions for both these activities in several mouse tissues have been optimized to facilitate the enzymatic characterization of homozygous and heterozygous twitcher mice. Galcerase in mouse tissues is optimally activated by 7.0 mg/ml of sodium taurocholate (pure) and 1.5-2.0 mg/ml of oleic acid in this system. When lactosylceramide is used as the substrate, no more than 1 mg/ml of taurocholate is appropriate in the assay, since higher concentrations of this pure bile salt stimulate another enzyme, lactosylceramide beta-galactosidase II (lactosidase II), which is unaffected in twitcher mice. At the optimized condition, lactosidase I in the twitcher mouse amounts to 3-4% of control activity in agreement with the residual galcerase (2%) in this mouse mutant. These assay conditions provide better sensitivity to discriminate heterozygotes from controls until 40 days of age from measurement of this activity in clipped tail samples.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/CDw17 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosidases,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosylceramidase,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosphingolipids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Lactosylceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Oleic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Oleic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Taurocholic Acid
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0006-3002
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
11
|
|
pubmed:volume |
877
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:3718992-Animals,
pubmed-meshheading:3718992-Animals, Newborn,
pubmed-meshheading:3718992-Animals, Suckling,
pubmed-meshheading:3718992-Antigens, CD,
pubmed-meshheading:3718992-Brain,
pubmed-meshheading:3718992-Galactosidases,
pubmed-meshheading:3718992-Galactosylceramidase,
pubmed-meshheading:3718992-Glycosphingolipids,
pubmed-meshheading:3718992-Heterozygote,
pubmed-meshheading:3718992-Homozygote,
pubmed-meshheading:3718992-Hydrolases,
pubmed-meshheading:3718992-Kidney,
pubmed-meshheading:3718992-Kinetics,
pubmed-meshheading:3718992-Lactosylceramides,
pubmed-meshheading:3718992-Liver,
pubmed-meshheading:3718992-Lysosomes,
pubmed-meshheading:3718992-Mice,
pubmed-meshheading:3718992-Mice, Inbred C57BL,
pubmed-meshheading:3718992-Mice, Neurologic Mutants,
pubmed-meshheading:3718992-Oleic Acid,
pubmed-meshheading:3718992-Oleic Acids,
pubmed-meshheading:3718992-Spleen,
pubmed-meshheading:3718992-Taurocholic Acid
|
|
pubmed:year |
1986
|
|
pubmed:articleTitle |
Optimal assay conditions for enzymatic characterization of homozygous and heterozygous twitcher mouse.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
